Thrombosis and Inflammation in Vessels Initiative (TIVI)
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 1,000
- 试验地点
- 1
- 主要终点
- This is a disease discovery protocol and there are no specific endpoints associated with this protocol.
研究概览
简要总结
Background:
Diseases related to the immune system, blood clots, and blood vessels can affect every part of the body. These diseases are now known to be interrelated: People who have strokes, blood clots in their legs, or autoimmune disease, for example, are at greater risk of complications in the heart, brain, and other organs. Researchers want to learn more about how these diseases start, how they change over time, and how they affect different organs.
Objective:
To learn more about how inflammation and diseases of the blood vessels start and how they change over time.
Eligibility:
People aged 5 years and older with a disease related to blood clots, the immune system, or blood vessels. Healthy relatives of people with these diseases and unrelated healthy volunteers are also needed.
Design:
Participants will have a baseline visit: They will provide a medical history, physical exam and blood test. All other tests and procedures are optional; these may be spread over more than 1 day:
Tests of heart and lung function.
Fill in a family tree form.
Imaging scans
Treadmill or bike stress tests and a 6-minute walk test.
Tests of blood pressure and the flow of blood through vessels.
Photos of the face and body.
Eye exams, with photos taken of the retina.
Saliva and urine samples.
Biopsies (tissues samples) of the skin and fat.
Tests of thinking and mental function.
Evaluations by other medical specialists.
Participants may opt to return for repeat testing for up to 90 months (7.5 years).
Some visits may be done by telehealth.
详细描述
Study Description:
Thrombotic vascular disorders remain the leading cause of morbidity and mortality in the United States. The proximate determinants of thrombosis, arterial, venous, and lymphatic vascular disorders and their treatments remains incompletely understood. In pursuit of improved vascular health, this disease discovery protocol will facilitate rapid initiation of new clinical and molecular phenotype-specific investigations to collect data and biospecimens on affected individuals, family members, and unrelated healthy controls. The data collected in this protocol will inform the design of future disease-specific investigational protocols.
Objectives:
Primary Objective:
To study the pathogenesis of patients affected with thrombotic, immune, vascular, and cardiovascular conditions including clinical, radiographic, immunological and genetic characteristics of the disease.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 年龄范围
- 5 Years 至 100 Years（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •INCLUSION CRITERIA:
- •In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- •Age >= 5 years at the time of consent
- •Ability of subject or Legally Authorized Representative (LAR) as applicable to understand and the willingness to sign a written informed consent document
- •In addition, the following cohort-specific inclusion criteria apply:
- •Affected Subjects:
- •Known or possible thrombotic, immune, or vascular disorder after review of the subject s medical records and/or discussion of medical history
- •Relatives of Affected Subjects:
- •Being a relative of an affected subject
- •Unrelated Healthy Controls:
- •In good general health as evidenced by medical history
排除标准
- •An individual who meets any of the following criteria will be excluded from participation in this study:
- •Any condition that in the opinion of the Investigator would warrant exclusion
- •Unrelated Healthy Controls:
- •Unrelated healthy volunteers who decline to have blood drawn and/or tissue studies or who do not consent to have samples stored for future research
- •Cognitively impaired individuals
研究组 & 干预措施
Affected Participants and Relatives
Participants with relevant immune, inflammation, thrombotic and/or vascular diseases and their relatives
Healthy Volunteers
Healthy volunteers
结局指标
主要结局
This is a disease discovery protocol and there are no specific endpoints associated with this protocol.
时间窗: Study End
次要结局
未报告次要终点